Aptose Biosciences Inc.
APTOF
Revenue
0.00
0.000.00%
-Assets
11.61M
▼-9.64M▼-45.36%
12 Months ChangeLiabilities
25.79M
▲5.83M▲29.20%
3 Months ChangeFree Cash Flow
-13.53M
▼-6.55M▼-93.90%
9 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-02-24
Form 8-K
ID: 0001193125-26-064847
2025-12-19
Form 8-K
ID: 0001171843-25-008045
2025-12-08
Form 8-K
ID: 0001171843-25-007795
2025-11-25
Form 8-K
ID: 0001193125-25-294108
2025-11-19
Form 8-K
ID: 0001171843-25-007415
2025-11-13
Form 10-Q
ID: 0001193125-25-280433
2025-11-13
Form 8-K
ID: 0001171843-25-007293
2025-11-03
Form 8-K
ID: 0001171843-25-006885
2025-10-16
Form 8-K
ID: 0001171843-25-006472
2025-09-22
Form 8-K
ID: 0001171843-25-005992